Pregnancy does not cure autoimmune diseases, but it can temporarily suppress symptoms of certain conditions, sometimes dramatically. Between 60% and 80% of women with rheumatoid arthritis experience significant improvement or remission during pregnancy. Multiple sclerosis relapse rates drop. Hashimoto’s thyroiditis quiets down. But these improvements almost always reverse after delivery, often within the first three months postpartum. The underlying disease remains.
Why Pregnancy Calms Certain Autoimmune Conditions
Your immune system faces a unique challenge during pregnancy: the fetus carries genetic material from both parents, making it partially foreign. To prevent rejection, the body shifts its immune activity away from the aggressive, inflammatory responses that characterize many autoimmune diseases.
This shift centers on two branches of the immune system. The branch responsible for inflammation (called Th1) gets dialed down, while the branch associated with anti-inflammatory activity (Th2) takes priority. In practical terms, the proportion of immune cells producing key inflammatory signals drops substantially during pregnancy. One study found that the percentage of certain immune cells generating a major inflammatory signal fell from about 10.7% in non-pregnant women to just 5.1% at full term. Importantly, the balance tips because inflammation is suppressed, not because anti-inflammatory activity ramps up dramatically.
At the same time, a specialized type of immune cell called a regulatory T cell expands in number. These cells act like peacekeepers, actively dampening destructive immune responses. They accumulate in the uterine lining and rise in the bloodstream starting in the first trimester. Their job is to prevent the mother’s immune system from attacking the fetus, but the suppressive effect spills over into the rest of the body, quieting autoimmune activity along the way.
Hormones also play a role. Estriol, a form of estrogen produced in large quantities only during pregnancy, appears to have a unique ability to reduce the kind of antibody-driven immune attacks that target the body’s own tissues. Unlike the estrogen present in non-pregnant women, estriol selectively dials down certain antibody responses while preserving the ability to fight bacteria. This selective effect may explain part of the symptom relief pregnant women with autoimmune conditions experience.
Rheumatoid Arthritis: The Strongest Responder
Rheumatoid arthritis is the autoimmune condition most consistently improved by pregnancy. Roughly 60% to 80% of women with RA notice their joint pain, swelling, and stiffness improve during pregnancy, with some reaching full remission. The relief tends to build gradually, with many women feeling their best in the second and third trimesters as the immune shift deepens.
This improvement is real but temporary. The first three months after delivery are a particularly vulnerable window. As pregnancy hormones drop and the immune system snaps back to its pre-pregnancy state, RA symptoms commonly return, and some women experience flares more intense than what they had before conceiving.
Multiple Sclerosis and Thyroid Disease
MS relapse rates fall during pregnancy, following a pattern similar to RA. The inflammatory immune activity that damages the protective coating around nerves is suppressed by the same Th1-to-Th2 shift that protects the fetus. After delivery, relapse rates rise during the first three months postpartum before settling back to pre-pregnancy levels.
Thyroid autoimmune conditions like Hashimoto’s thyroiditis and Graves’ disease also tend to quiet down during pregnancy. Antibodies that attack the thyroid gland decline steadily, reaching their lowest point in the third trimester. Postpartum, those antibody levels rebound. In one finding, 70% of mothers who tested positive for thyroid-stimulating antibodies during screening went on to develop either temporary or permanent postpartum Graves’ disease within three to six months of giving birth.
Lupus: The Notable Exception
Not all autoimmune diseases improve during pregnancy. Systemic lupus erythematosus, or lupus, can actually worsen. Women with active lupus at the time of conception face a higher risk of flares during pregnancy, particularly those with a history of kidney involvement. Lupus is driven partly by Th2-type immune activity and antibody production, so the pregnancy-related shift toward Th2 dominance can feed the disease rather than calm it.
Complicating matters further, normal pregnancy symptoms like joint pain, fatigue, rashes, and swelling can closely mimic a lupus flare, making it harder to tell whether the disease is actually worsening or the body is simply responding to pregnancy itself.
What Happens After Delivery
The postpartum period is, immunologically speaking, the mirror image of pregnancy. Hormones drop rapidly. The immune system rebounds from its suppressed state, and inflammatory activity surges. This rebound is why autoimmune symptoms so reliably return, and why the first three months after birth represent the highest-risk period for flares across nearly every autoimmune condition that improved during pregnancy.
For some women, the postpartum period doesn’t just restore their pre-pregnancy disease activity. It can trigger new autoimmune conditions or unmask ones that hadn’t yet caused symptoms. Postpartum thyroiditis is the most common example, but new-onset RA, MS relapses, and lupus flares all occur at elevated rates in the months following delivery.
Fetal Cells Linger, but Don’t Change the Disease
During pregnancy, a small number of fetal cells cross the placenta and take up residence in the mother’s body, sometimes persisting for decades. This phenomenon, called fetal microchimerism, has generated considerable interest in autoimmune research. Fetal cells have been detected in women with RA and lupus at significantly higher rates than in healthy controls: roughly 18% of RA patients and 31% of lupus patients had detectable fetal cells decades after their last pregnancy, compared to just 3.7% of women without autoimmune disease.
However, these lingering cells don’t appear to change the course of the disease. Studies have found no significant difference in disease onset timing, severity markers, or antibody profiles between women with and without detectable fetal cells. The cells may simply be a byproduct of the immune dysregulation already present in autoimmune conditions rather than a driver of it.
Planning Pregnancy With an Autoimmune Disease
European clinical guidelines emphasize that stable, well-controlled disease is the single most important factor for a healthy pregnancy in women with autoimmune conditions. The recommendation is straightforward: aim for remission or low disease activity on pregnancy-compatible medications before conceiving. When disease is active, conception should be postponed until treatment brings it under better control.
This matters because the temporary improvement pregnancy brings is unpredictable. Not every woman with RA will improve. Not every woman with MS will avoid relapses. And for conditions like lupus, pregnancy can make things worse. Starting from a place of disease control gives both mother and baby the best odds, regardless of what the immune shift of pregnancy does or doesn’t deliver.